Avery Therapeutics is focused on creating innovative immunomodulatory biologic therapeutics aimed at enhancing human health. Their approach centers on a novel platform designed to address diseases associated with aging, inflammation, and fibrosis. By leveraging this technology, the company aims to redirect the immune system's response, which can lead to the restoration of organ function and an overall improvement in the quality of life for patients.

The core of Avery Therapeutics' technology lies in its adaptive biologic, which is engineered to modulate immune responses effectively. This platform represents a significant advancement in therapeutic strategies, as it not only targets the underlying mechanisms of various diseases but also seeks to promote healing and regeneration within affected organs. Through this innovative approach, Avery Therapeutics is positioned to make meaningful contributions to the field of medicine, particularly in the management of chronic conditions related to immune dysfunction.

United States

Avery Therapeutics is developing first-in-class immunomodulatory therapeutics to redirect the immune system to address diseases of aging, inflammation, and fibrosis. Avery's lead program is under development for heart failure, one of the leading causes of death in the world.

Avery Therapeutics

Company Details